Clover Corporation Limited (CLV.AX) Stock Analysis & Winston Score
Clover Corporation is an Australian food ingredients company that specializes in encapsulated omega-3 oils, primarily derived from fish and algae. These ingredients are sold to infant formula makers, food manufacturers, and nutritional supplement companies who add them to their products. Clover is one of a small number of companies globally that uses microencapsulation technology to stabilize omega-3 oils, which prevents them from going rancid and makes them easier to add to powdered foods like baby formula. The company earns revenue by selling its encapsulated ingredients in bulk to other food and nutrition businesses, making it a business-to-business supplier rather than a consumer brand. Clover operates primarily in Australia but sells to customers across Asia, Europe, and North America, with the infant formula market in China being a meaningful end market. Its proprietary encapsulation process provides some competitive protection, but the business faces risk from shifts in infant formula demand, particularly in China, where birth rates have been declining steadily.
Winston Score: 66/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (17/30)
- Growth: Strong (15/20)
- Cash Flow: Mixed (3/10)
- Stability: Exceptional (10/10)
- Valuation: Strong (7/10)
- Ownership: Good (10/15)
Key Facts
Price: 0.90 AUD
Market Cap: 150M AUD
Sector: Consumer Defensive
Industry: Packaged Foods
Exchange: Australian Securities Exchange

